Mode
Text Size
Log in / Sign up
N/A N=243 Randomized Single-blind Treatment

Total Hip Replacement Performance & Assessment

Hip Osteoarthritis

Enrolled (actual)
243
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Surgeon Participant Intra-operative Motion Analysis — 171,967; 172,258; 150,505 Movement counts

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Surgical simulation training in primary Total Hip Arthroplasty (Behavioral); No intervention: Surgical Resident Control Group (Other); No Intervention: Consultant and Fellow Comparator Group (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Oxford
Primary completion
Feb 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Surgeon Participant Intra-operative Motion Analysis
171,967; 172,258; 150,505
PRIMARY
Surgeon Participant Intra-operative Timings
4948; 4428; 3679
PRIMARY
Surgical Trainee Global Rating Scale (GRS)
30; 31
PRIMARY
Percent of Participants With 4+ Objective Structured Assessment of Technical Skills (OSATS) Rating.
55.5; 37.5
SECONDARY
Post-operative Patient X-ray
42.2; 43.0; 41.9
SECONDARY
Patient Blood Loss.
339; 274; 316
SECONDARY
Number of Participants Requiring a Blood Transfusion.
0; 1; 1
SECONDARY
Patient Hospital Length of Stay
2.95; 3.37; 2.41
SECONDARY
Oxford Hip Score
26; 24; 25
SECONDARY
EQ-5D
19; 19; 19

Summary

This research study is focused upon assessing and optimising surgeon's performance during, and patient outcomes following, primary total hip replacement (THR) surgery. The primary research question is to determine if additional simulation training can improve the intra-operative performance of surgical trainees (Residents) during a THR, or the outcome of patients after their THR. The investigators will aim to define an 'expert' standard in performing a primary elective THR, which may be used as a benchmark when assessing surgical trainee performance; and also determine if operative surgeon performance metrics during a THR are correlated with surgical experience, or patient outcomes.

Eligibility Criteria

Inclusion Criteria

  • Adult patients diagnosed with primary hip osteoarthritis who have been listed for elective primary Total Hip Replacement within the United Kingdoms National Health Service.
  • Total Hip Replacement performed by a surgeon participant as lead surgeon.

Exclusion Criteria

  • Patients with complex hip pathology (e.g. previous trauma, hip dysplasia, infection).
  • Patients who have had previous surgery on their affected hip.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04267172). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search